Table 2.
Differences among mineral metabolism biochemical features in COVID-19 patients
| Variables | p value | ||
|---|---|---|---|
| VD deficiency | VD sufficiency | ||
| tCa levels, mmol/L | 2.12 (2.05–2.21) | 2.18 (2.13–2.28) | p = 0.018 |
| Ca2+ levels, mmol/L | 1.14 (1.1–1.18) | 1.16 (1.12–1.18) | p = 0.24 |
| PTH levels, pg/mL | 49.1 (39.1–64.8) | 41.8 (30.2–63.1) | p = 0.1 |
| tCa-hypocalcemic | tCa-normocalcemic | ||
| VD levels, ng/mL | 16.2 (10.9–21.4) | 18.5 (13–28.8) | p = 0.1 |
| PTH levels, pg/mL | 46 (38.6–65.6) | 44 (29.2–53.6) | p = 0.048 |
| Ca2+-hypocalcemic | Ca2+-normocalcemic | ||
| VD levels, ng/mL | 16.3 (12.8–23) | 16.8 (10.8–28.1) | p = 0.41 |
| PTH levels, pg/mL | 46 (36.7–64.8) | 44.1 (26.1–53.2) | p = 0.19 |
| Hyperparathyroid | Normal PTH | ||
| tCa levels, mmol/L | 2.05 (1.93–2.17) | 2.16 (2.07–2.24) | p = 0.017 |
| Ca2+ levels, mmol/L | 1.1 (1.09–1.14) | 1.16 (1.12–1.18) | p = 0.029 |
| VD levels, ng/mL | 16.1 (10.3–21.8) | 16.5 (13.2–24.1) | p = 0.3 |
P values reported in bold are statistically significant.VD vitamin D, tCa total calcium, Ca2+ ionized calcium, PTH parathyroid hormone